Brief: Portage Biotech Reports Promising Preclinical Results In Mesothelioma Supporting First-In-Human Trial Of Port-7
27/03/2025 20:46
March 27 (Reuters) - Portage Biotech Inc PRTG.O: PORTAGE BIOTECH REPORTS PROMISING PRECLINICAL RESULTS IN MESOTHELIOMA SUPPORTING FIRST-IN-HUMAN TRIAL OF PORT-7 Source text: ID:nGNX1x9XGg Further company coverage: PRTG.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alpha Compute
See all newsBrief: Alpha Compute Corp. Provides Mid-Q2 2026 Update
Brief: Alpha Compute Ai Gpu Launch Update First Large-Scale Nvidia Blackwell Cluster
Brief: Alpha Compute Appoints Tom Richer To Advisory Board To Accelerate Ai Gpu Compute Infrastructure And Confidential Cloud Strategy
Brief: Alphaton Capital Rebrands As Alpha Compute Corp. To Reflect Its Growing Ai Compute Business
Brief: Alphaton Capital Announces $43 Million Ai Infrastructure And Financing Partnership With Vertical Data